Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bridging antiplatelet therapy with tirofiban for urgent surgery after recent drug-eluting stent implantation
2008-000561-28Phase 2Completed
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Sep 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tirofiban and eptifibatide in cardiac ischemia and coronary arteriosclerosis, sponsored by ASST Grande Ospedale Metropolitano Niguarda. Primary endpoints: Composite ischemic and bleeding endpoint, Cardiovascular death and 3 more. Started Sep 2009; status: completed.
02
Drugs
tirofibaneptifibatide
03
Conditions
cardiac ischemiacoronary arteriosclerosis
Beyond the preview
Go deeper on 2008-000561-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000561-28.